Felicitas Josephine Detmer, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aneurysm, Ruptured | 10 | 2020 | 452 | 3.610 |
Why?
|
| Intracranial Aneurysm | 11 | 2020 | 1197 | 2.510 |
Why?
|
| Hemodynamics | 9 | 2020 | 4197 | 1.670 |
Why?
|
| Decision Trees | 1 | 2019 | 506 | 0.610 |
Why?
|
| Models, Statistical | 3 | 2019 | 5100 | 0.540 |
Why?
|
| Doxorubicin | 1 | 2022 | 2215 | 0.530 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2018 | 1440 | 0.410 |
Why?
|
| Cerebral Angiography | 4 | 2020 | 1285 | 0.370 |
Why?
|
| ROC Curve | 3 | 2019 | 3528 | 0.290 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2019 | 4029 | 0.270 |
Why?
|
| Hydrodynamics | 3 | 2019 | 158 | 0.230 |
Why?
|
| Models, Cardiovascular | 2 | 2019 | 994 | 0.230 |
Why?
|
| Probability | 2 | 2019 | 2502 | 0.220 |
Why?
|
| Kidney | 1 | 2017 | 7167 | 0.200 |
Why?
|
| Mitochondria, Heart | 1 | 2022 | 247 | 0.180 |
Why?
|
| Organophosphorus Compounds | 1 | 2021 | 215 | 0.180 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2022 | 692 | 0.160 |
Why?
|
| Finland | 1 | 2019 | 602 | 0.160 |
Why?
|
| Body Fluids | 1 | 2019 | 319 | 0.150 |
Why?
|
| Pulsatile Flow | 1 | 2018 | 332 | 0.150 |
Why?
|
| Positron-Emission Tomography | 3 | 2022 | 6259 | 0.140 |
Why?
|
| Japan | 1 | 2019 | 1360 | 0.130 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 1423 | 0.120 |
Why?
|
| Incidental Findings | 1 | 2019 | 688 | 0.120 |
Why?
|
| Area Under Curve | 1 | 2018 | 1653 | 0.120 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 1636 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 2 | 2020 | 2732 | 0.110 |
Why?
|
| Middle Aged | 7 | 2020 | 213127 | 0.100 |
Why?
|
| Myocardium | 2 | 2021 | 4775 | 0.100 |
Why?
|
| Aged | 6 | 2020 | 162944 | 0.090 |
Why?
|
| Male | 8 | 2020 | 349538 | 0.080 |
Why?
|
| Humans | 15 | 2021 | 742088 | 0.070 |
Why?
|
| Female | 7 | 2020 | 379592 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2019 | 6191 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 3328 | 0.070 |
Why?
|
| Adult | 5 | 2020 | 213712 | 0.070 |
Why?
|
| Sex Factors | 1 | 2018 | 10392 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2019 | 7716 | 0.060 |
Why?
|
| Logistic Models | 1 | 2018 | 13403 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 18006 | 0.060 |
Why?
|
| Stress, Mechanical | 2 | 2019 | 1684 | 0.050 |
Why?
|
| Models, Biological | 1 | 2018 | 9581 | 0.050 |
Why?
|
| Risk Factors | 5 | 2020 | 72145 | 0.050 |
Why?
|
| Age Factors | 1 | 2018 | 18355 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2019 | 23320 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 8925 | 0.050 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2021 | 297 | 0.040 |
Why?
|
| Mast Cells | 1 | 2005 | 1544 | 0.040 |
Why?
|
| Carotid Artery, Internal | 1 | 2020 | 445 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 24913 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2005 | 2006 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20086 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2020 | 1135 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2018 | 40450 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2005 | 3038 | 0.030 |
Why?
|
| Animals | 2 | 2022 | 168561 | 0.030 |
Why?
|
| Young Adult | 1 | 2018 | 56350 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5062 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 77098 | 0.020 |
Why?
|
| Computational Biology | 1 | 2019 | 3518 | 0.020 |
Why?
|
| Chymases | 1 | 2005 | 99 | 0.020 |
Why?
|
| Cyclooxygenase 1 | 1 | 2005 | 104 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2005 | 370 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 2005 | 219 | 0.020 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 329 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2005 | 314 | 0.010 |
Why?
|
| Receptors, IgE | 1 | 2005 | 389 | 0.010 |
Why?
|
| Prevalence | 1 | 2020 | 15194 | 0.010 |
Why?
|
| Smoking | 1 | 2020 | 8969 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 611 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 2005 | 491 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2005 | 644 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2005 | 774 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2005 | 1866 | 0.010 |
Why?
|
| Hypertension | 1 | 2020 | 8455 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2005 | 1073 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4751 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 5180 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2005 | 1889 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 57683 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2005 | 10472 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 19223 | 0.010 |
Why?
|
| Apoptosis | 1 | 2005 | 9715 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2005 | 7873 | 0.000 |
Why?
|